VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Quoin Pharmaceuticals, Ltd. (QNRX) Total Return Calculator with Dividends Reinvested

Quoin Pharmaceuticals, Ltd.

Popular:

The total return for Quoin Pharmaceuticals, Ltd. (QNRX) stock is +3.75% over the past 12 months. So far it's down 54.76% this year. The 5-year total return is -99.99%, meaning $10,000 invested in QNRX stock 5 years ago would be worth $1 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in QNRX 1 year ago, it would be worth $10,176 today — you'd have gained $176.

With Dividends Reinvested$10,176+1.76%

Price Only (No DRIP)$10,176+1.76%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in QNRX

1Y$10,375+$375 (+3.7%)3.7% CAGR

3Y$267-$9,733 (-97.3%)-70.1% CAGR

5Y$1-$9,999 (-100.0%)-83.5% CAGR

10Y$0-$10,000 (-100.0%)-68.1% CAGR

15Y$0-$10,000 (-100.0%)-53.3% CAGR

20Y$0-$10,000 (-100.0%)-43.5% CAGR

30Y$0-$10,000 (-100.0%)-31.7% CAGR

Quoin Pharmaceuticals, Ltd. did not pay dividends during this period. Total return = price return.

Loading QNRX total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-54.76%	—	-54.76%	—	$4,524
1Y	+3.75%	3.75%	+3.75%	—	$10,375
3Y	-97.33%	-70.11%	-97.33%	—	$267
5Y	-99.99%	-83.54%	-99.99%	—	$1
10Y	-100.00%	-68.07%	-100.00%	—	$0
15Y	-100.00%	-53.29%	-100.00%	—	$0
20Y	-100.00%	-43.50%	-100.00%	—	$0
30Y	-100.00%	-31.65%	-100.00%	—	$0

Risk & Highlights

Best Year+128.16%2017

Worst Year-94.69%2022

Max Drawdown-75.56%2025-11-25 → 2026-04-28

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-40.55%	-40.55%	—	+0.41%	-41.0pp
2025	-38.65%	-38.65%	—	+16.64%	-55.3pp
2024	-86.54%	-86.54%	—	+24.00%	-110.5pp
2023	-72.00%	-72.00%	—	+24.81%	-96.8pp
2022	-94.69%	-94.69%	—	-19.95%	-74.7pp

QNRX underperformed the S&P 500 by 26.63pp over the past year (+3.75% vs +30.37%).

Loading summary...

QNRX Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
QNRXQuoin Pharmaceuticals, Ltd.	$4M	+0.8%	-54.8%	+3.7%	—	-97.3%	-100.0%	-100.0%
RAREUltragenyx Pharmaceutical Inc.	$2.6B	+12.9%	+10.7%	-21.8%	—	-44.5%	-77.2%	-59.4%
FOLDAmicus Therapeutics, Inc.	$4.5B	+0.1%	+1.5%	+137.9%	—	+19.0%	+48.6%	+119.2%
PTCTPTC Therapeutics, Inc.	$5.3B	-7.3%	-16.0%	+58.2%	—	+16.1%	+60.3%	+733.2%
NVCRNovoCure Limited	$1.9B	+62.6%	+28.3%	+1.1%	—	-75.7%	-91.3%	+30.3%
PRAXPraxis Precision Medicines, Inc.	$9.6B	+8.7%	+16.4%	+775.0%	—	+1976.5%	-20.8%	-20.1%
RCKTRocket Pharmaceuticals, Inc.	$398M	+5.5%	+6.1%	-45.2%	—	-82.8%	-91.6%	-91.3%
KRYSKrystal Biotech, Inc.	$8.7B	+12.4%	+20.2%	+116.9%	—	+238.5%	+319.2%	+2688.5%
BEAMBeam Therapeutics Inc.	$3.2B	+28.5%	+16.0%	+93.9%	—	-5.6%	-55.6%	+67.8%
EDITEditas Medicine, Inc.	$297M	+10.6%	+47.8%	+127.8%	—	-68.5%	-91.1%	-90.0%
IQVIQVIA Holdings Inc.	$30.3B	+4.7%	-20.7%	+16.5%	—	-5.9%	-23.8%	+166.5%

Compare:QNRX vs RARE QNRX vs FOLD QNRX vs PTCT QNRX vs RARE vs FOLD

About QNRX Dividend Returns

Quoin Pharmaceuticals, Ltd. (QNRX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of QNRX over the past year?

Quoin Pharmaceuticals, Ltd. (QNRX) delivered a return of 3.75% over the past year. Since QNRX does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in QNRX be worth today?

A $10,000 investment in Quoin Pharmaceuticals, Ltd. one year ago would be worth $10,375 today, representing a gain of $375.

Q3Does QNRX pay dividends?

Quoin Pharmaceuticals, Ltd. (QNRX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For QNRX, the total return equals the price-only return.

Q4Did QNRX beat the S&P 500?

No, Quoin Pharmaceuticals, Ltd. (QNRX) underperformed the S&P 500 by 26.63 percentage points over the past year. QNRX delivered a total return of 3.75%, compared to the S&P 500's 30.37%. This means a passive S&P 500 index fund outperformed QNRX by 26.63pp during this period.

Q5What is QNRX's worst drawdown?

Quoin Pharmaceuticals, Ltd. (QNRX) experienced a maximum drawdown of -75.56% over the past year, declining from its peak on 2025-11-25 to its trough on 2026-04-28. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is QNRX's long-term total return over 10, 20, or 30 years?

Here are Quoin Pharmaceuticals, Ltd. (QNRX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -100.0% (-68.1% CAGR) — $10,000 would have grown to $0. Over 20 years: -100.0% total return (-43.5% CAGR) — $10,000 → $0. Over 30 years: -100.0% total return (-31.7% CAGR) — $10,000 → $0. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was QNRX's best and worst year?

Quoin Pharmaceuticals, Ltd.'s best calendar year was 2017 with a total return of 128.2%. Its worst year was 2022 with a total return of -94.7%. This range shows the volatility investors should expect — the difference between the best and worst year is 222.9 percentage points.